(Q79691224)
Statements
Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1 (English)
Xiaoyan Yu
Cai Li
Xiaokun Li
29 January 2007
scientific article published on 29 January 2007